Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Recherche avancée dans les brevets | Historique Web | Connexion

Brevets

Référencé par

Brevet citant Date de dépôt Date de délivrance Cessionnaire d'origine Titre
US39760717 janv. 197424 août 1976Dynatech CorporationMethods of improving control of release rates and products useful in same
US39917663 avr. 197516 nov. 1976American Cyanamid CompanyControlled release of medicaments using polymers from glycolic acid
US40013882 juil. 19754 janv. 1977Alza CorporationOphthalmological bioerodible drug dispensing formulation
US401131225 juin 19758 mars 1977American Home Products CorporationProlonged release drug form for the treatment of bovine mastitis
US40667478 avr. 19763 janv. 1978Alza CorporationPolymeric orthoesters housing beneficial drug for controlled release therefrom
US409370928 janv. 19756 juin 1978Alza CorporationDrug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US411554410 nov. 197719 sept. 1978Alza CorporationOcular system made of bioerodible esters having linear ether
US413834424 août 19776 févr. 1979ALZA CorporationErodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates)
US414887111 oct. 197710 avr. 1979Sustained subdermal delivery ofdrugs using poly(.epsilon.-caprolactone) and its copolymers
US423975528 juin 197916 déc. 1980The United States of America as represented by the Department of Health, Education and WelfareSteroidal cyclotriphosphazenes
US427239815 juin 19799 juin 1981The United States of America as represented by the Secretary of AgricultureMicroencapsulation process
US427392012 sept. 197916 juin 1981Eli Lilly and CompanyPolymerization process and product
US42910139 oct. 197922 sept. 1981Merck Patent Gesellschaft Mit Beschrankter HaftungMedicinally useful, shaped mass of collagen resorbable in the body
US429353912 sept. 19796 oct. 1981Eli Lilly and CompanyControlled release formulations and method of treatment
US432239821 févr. 197930 mars 1982Battelle Institut e.V.Implantable drug depot and process for the production thereof
US43265229 juin 198027 avr. 1982Pitman-Moore, Inc.Mesh-covered bolus
US433165224 déc. 198025 mai 1982Eli Lilly and CompanyControlled release parasitic formulations and method
US433391915 déc. 19808 juin 1982Eli Lilly and CompanyGrowth promotant controlled release formulations and method of treatment
US434723415 juin 198131 août 1982Merck Patent Gesellschaft mit beschrankter HaftungMedicinally useful, shaped mass of collagen resorbable in the body
US435133711 sept. 198028 sept. 1982Arthur D. Little, Inc.Biodegradable, implantable drug delivery device, and process for preparing and using the same
US441934020 nov. 19806 déc. 1983University of DelawareControlled release of anticancer agents from biodegradable polymers
US44915756 oct. 19831 janv. 1985Chemie Linz AktiengesellschaftCompressed products with retarded release of active substance, a process for their preparation and a process for the long-term administration of medicaments
US452693815 avr. 19832 juil. 1985Imperial Chemical Industries PLCContinuous release formulations
US457838415 févr. 198425 mars 1986The United States of America as represented by the Secretary of the ArmyPolylactic-polyglycolic acids combined with an acidic phospholipid-lysozyme complex for healing osseous tissue
US458565118 déc. 198029 avr. 1986Stolle Research & Development CorporationActive/passive immunization of the internal female reproductive organs
US462224423 août 198411 nov. 1986The Washington UniversityProcess for preparation of microcapsules
US46490423 avr. 198510 mars 1987Eli Lilly and CompanyRumen delivery device
US466670211 avr. 198519 mai 1987Thiemann Arzneimittel GmbHDosage units for controlled release of active material
US46751898 févr. 198523 juin 1987Syntex (U.S.A.) Inc.Microencapsulation of water soluble active polypeptides
US468588326 juil. 198511 août 1987Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US470291718 nov. 198527 oct. 1987Research Triangle InstitutePorous bioabsorbable polyesters
US470736215 févr. 198517 nov. 1987Biotek, Inc.Sustained release composition
US473276328 sept. 198422 mars 1988Stolle Research and Development CorporationActive/passive immunization of the internal female reproductive organs
US474516021 juin 198517 mai 1988Imperial Chemical Industries PLCBiodegradable amphipathic copolymers
US47547457 juil. 19865 juil. 1988Conformable sheet material for use in brachytherapy
US47636427 avr. 198616 août 1988Intracavitational brachytherapy
US476762829 juin 198730 août 1988Imperial Chemical Industries PLCContinuous release pharmaceutical compositions
US477409131 mars 198627 sept. 1988Sumitomo Pharmaceuticals Company, Ltd.Long-term sustained-release preparation
US480662121 janv. 198621 févr. 1989Massachusetts Institute of TechnologyBiocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
US481544930 mars 198728 mars 1989Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US483268624 juin 198623 mai 1989Method for administering interleukin-2
US483513919 mai 198730 mai 1989Debiopharm S.A.Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases
US484196826 sept. 198627 juin 1989Southern Research Institute
Texas Health Science Center
Antithrombotic/thrombolytic suture and methods of making and using the same
US48570495 août 198615 août 1989Kortum, Inc.Method and apparatus for inducing immunological and resistant response in mammary glands
US487154230 avr. 19873 oct. 1989Ferring Service Center, N.V.Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
US487760619 janv. 198831 oct. 1989Imperial Chemical Industries PLCBiodegradable amphipathic copolymers
US48972683 août 198730 janv. 1990Southern Research InstituteDrug delivery system and method of making the same
US489873429 févr. 19886 févr. 1990Massachusetts Institute of TechnologyPolymer composite for controlled release or membrane formation
US492741924 avr. 198722 mai 1990Agri Research and DevelopmentSustained release medicating device for livestock
US49387633 oct. 19883 juil. 1990Biodegradable in-situ forming implants and methods of producing the same
US494058817 mars 198810 juil. 1990Elan CorporationControlled release powder and process for its preparation
US49617076 juin 19899 oct. 1990University of FloridaGuided periodontal tissue regeneration
US500460212 mai 19862 avr. 1991Imperial Chemical Industries PLCContinuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide
US502124128 avr. 19884 juin 1991Sumitomo Pharmaceuticals Company, LimitedLong-term sustained-release preparation
US511059519 juin 19875 mai 1992Implant preparations containing bioactive macromolecule for sustained delivery
US511471914 sept. 198919 mai 1992Extended drug delivery of small, water-soluble molecules
US514202324 janv. 199225 août 1992Cargill, IncorporatedContinuous process for manufacture of lactide polymers with controlled optical purity
US51603418 nov. 19903 nov. 1992Advanced Surgical Intervention, Inc.Resorbable urethral stent and apparatus for its insertion
US520803226 juin 19924 mai 1993Rutgers, The State University of New JerseyIncreasing the growth of turkeys using implant of 19-nortestosterone
US52363555 oct. 199017 août 1993American Cyanamid CompanyApparatus for the treatment of periodontal disease
US52470587 août 199221 sept. 1993Cargill, IncorporatedContinuous process for manufacture of lactide polymers with controlled optical purity
US524705924 août 199221 sept. 1993Cargill, IncorporatedContinuous process for the manufacture of a purified lactide from esters of lactic acid
US52584887 août 19922 nov. 1993Cargill, IncorporatedContinuous process for manufacture of lactide polymers with controlled optical purity
US527407324 août 199228 déc. 1993Cargill, IncorporatedContinuous process for manufacture of a purified lactide
US527820124 avr. 199011 janv. 1994Atrix Laboratories, Inc.Biodegradable in-situ forming implants and methods of producing the same
US528676330 juin 199215 févr. 1994Massachusetts Institute of TechnologyBioerodible polymers for drug delivery in bone
US53388222 oct. 199216 août 1994Cargill, IncorporatedMelt-stable lactide polymer composition and process for manufacture thereof
US535058026 févr. 199327 sept. 1994Minnesota Mining and Manufacturing CompanyDevice and method for extended delivery of pharmacologically active agents to the ear
US535703516 sept. 199318 oct. 1994Cargill, IncorporatedContinuous process for manufacture of lactide polymers with purification by distillation
US536673328 mai 199122 nov. 1994American Cyanamid CompanyMethod for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, and composition of matter therefor
US536673422 août 199122 nov. 1994Zeneca LimitedContinuous release pharmaceutical compositions
US538433317 mars 199224 janv. 1995University of MiamiBiodegradable injectable drug delivery polymer
US540359513 oct. 19934 avr. 1995DynaGen, Inc.Controlled, sustained release delivery system for smoking cessation
US544411329 sept. 199322 août 1995Ecopol, LLCEnd use applications of biodegradable polymers
US545691712 janv. 199410 oct. 1995Cambridge Scientific, Inc.Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US54629905 oct. 199331 oct. 1995Board of Regents, The University of Texas SystemMultifunctional organic polymers
US547508022 mars 199312 déc. 1995Cargill, IncorporatedPaper having a melt-stable lactide polymer coating and process for manufacture thereof
US548488123 août 199316 janv. 1996Cargill, Inc.Melt-stable amorphous lactide polymer film and process for manufacturing thereof
US548636221 oct. 199323 janv. 1996DynaGen, Inc.Controlled, sustained release delivery system for treating drug dependency
US548789728 sept. 199330 janv. 1996Atrix Laboratories, Inc.Biodegradable implant precursor
US550022826 nov. 199019 mars 1996American Cyanamid CompanyPhase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
US55187303 juin 199221 mai 1996Fuisz Technologies Ltd.Biodegradable controlled release flash flow melt-spun delivery system
US552570625 oct. 199411 juin 1996Cargill, IncorporatedMelt-stable lactide polymer nonwoven fabric and process for manufacture thereof
US55365033 avr. 199516 juil. 1996DynaGen, Inc.Controlled, sustained release delivery system for smoking cessation
US553680723 août 199316 juil. 1996Cargill, IncorporatedMelt-stable semi-crystalline lactide polymer film and process for manufacture thereof
US55387337 juil. 199423 juil. 1996Willmar Poultry Company, Inc.Method of priming an immune response in a one-day old animal
US553908122 mai 199523 juil. 1996Cargill, IncorporatedMelt-stable lactide polymer composition and process for manufacture thereof
US554093727 juil. 199330 juil. 1996Rhone MerieuxProcess for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
US55454095 avr. 199413 août 1996Massachusetts Institute of TechnologyDelivery system for controlled release of bioactive factors
US558519113 sept. 199517 déc. 1996Cargill, IncorporatedMelt-stable amorphous lactide polymer film and process for manufacture thereof
US55995357 juin 19954 févr. 1997Regents of the University of CaliforniaMethods for the cyto-protection of the trabecular meshwork
US560768622 nov. 19944 mars 1997United States Surgical CorporationPolymeric composition
US56290097 août 199613 mai 1997Massachusetts Institute of TechnologyDelivery system for controlled release of bioactive factors
US56327277 juin 199527 mai 1997Atrix Laboratories, Inc.Biodegradable film dressing and method for its formation
US56330024 mai 199527 mai 1997Boehringer Ingelheim GmbHImplantable, biodegradable system for releasing active substance
US56562973 mai 199412 août 1997Alkermes Controlled Therapeutics, IncorporatedModulated release from biocompatible polymers
US566084923 août 199426 août 1997Atrix Laboratories, Inc.Apparatus for forming a biodegradable implant precursor
US566547431 août 19959 sept. 1997Cargill, IncorporatedPaper having a melt-stable lactide polymer coating and process for manufacture thereof
US56748887 juin 19957 oct. 1997University of CaliforniaMethod for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US568187314 oct. 199328 oct. 1997Atrix Laboratories, Inc.Biodegradable polymeric composition
US570047910 nov. 199423 déc. 1997Guidor ABSurgical element and method for selective tissue regeneration
US57027162 juin 199330 déc. 1997Atrix Laboratories, Inc.Polymeric compositions useful as controlled release implants
US570764714 nov. 199613 janv. 1998Atrix Laboratories, Inc.Adjunctive polymer system for use with medical device
US57170306 déc. 199610 févr. 1998Atrix Laboratories, Inc.Adjunctive polymer system for use with medical device
US57229507 juin 19953 mars 1998Atrix Laboratories, Inc.Method for remote delivery of an aerosolized liquid
US573395025 sept. 199531 mars 1998Atrix Laboratories, IncorporatedBiodegradable in-situ forming implants and methods of producing the same
US573615227 oct. 19957 avr. 1998Atrix Laboratories, Inc.Non-polymeric sustained release delivery system
US573917618 mars 199414 avr. 1998Atrix Laboratories, Inc.Biodegradable in-situ forming implants and methods of producing the same
US57414796 juin 199521 avr. 1998Gillette Canada Inc.Desensitizing teeth with degradable particles
US57441539 juin 199728 avr. 1998Atrix Laboratories, Inc.Liquid delivery compositions
US574706026 mars 19965 mai 1998Euro-Celtique, S.A.Prolonged local anesthesia with colchicine
US575665117 juil. 199626 mai 1998Chronopol, Inc.Impact modified polylactide
US57601185 juin 19952 juin 1998Chronopol, Inc.End use applications of biodegradable polymers
US576356429 mars 19969 juin 1998Cargill, IncorporatedMelt-stable lactide polymer composition and process for manufacture thereof
US577356228 févr. 199630 juin 1998Cargill, IncorporatedMelt-stable semi-crystalline lactide polymer film and process for manufacture thereof
US57800445 déc. 199614 juil. 1998Atrix Laboratories, Inc.Liquid delivery compositions
US578005122 janv. 199714 juil. 1998DynaGen, Inc.Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
US57924697 juin 199511 août 1998Atrix Laboratories, Inc.Biodegradable in situ forming film dressing
US57984365 sept. 199625 août 1998Cargill, IncorporatedMelt-stable amorphous lactide polymer film and process for manufacture thereof
US580797327 sept. 199515 sept. 1998Cargill, IncorporatedMelt-stable lactide polymer nonwoven fabric and process for manufacture thereof
US58111287 sept. 199322 sept. 1998Southern Research Institute
The UAB Research Foundation
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US58143446 juin 199529 sept. 1998Southern Research Institute
The UAB Research Foundation
Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release
US58208836 juin 199513 oct. 1998Southern Research Institute
The UAB Research Foundation
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release
US584988419 août 199615 déc. 1998Epic Therapeutics, Inc.Macromolecular microparticles and methods of production and use
US585216614 juil. 199722 déc. 1998Cargill, IncorporatedPaper having a melt-stable lactide polymer coating and process for manufacture thereof
US58537636 juin 199529 déc. 1998Southern Research Institute
The UAB Research Foundation
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release
US587645230 mai 19952 mars 1999Board of Regents, University of Texas SystemBiodegradable implant
US588853321 nov. 199730 mars 1999Atrix Laboratories, Inc.Non-polymeric sustained release delivery system
US590661715 août 199725 mai 1999Surgical repair with hook-and-loop fastener
US59068263 avr. 199625 mai 1999Willmar Poultry Company, Inc.Method of inducing an immune response in a young animal
US590891826 mai 19981 juin 1999Chronopol, Inc.Impact modified polylactide
US59120157 avr. 199815 juin 1999Alkermes Controlled Therapeutics, Inc.Modulated release from biocompatible polymers
US591659729 août 199629 juin 1999Alkermes Controlled Therapeutics, Inc.Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent
US592225318 mai 199513 juil. 1999Alkermes Controlled Therapeutics, Inc.Production scale method of forming microparticles
US592234016 sept. 199613 juil. 1999Children's Medical Center CorporationHigh load formulations and methods for providing prolonged local anesthesia
US592268211 févr. 199213 juil. 1999Novartis AGPolyol esters, their preparation and use in depot forms of pharmacologically active agents
US594224116 juin 199724 août 1999Euro-Celtique, S.A.Formulations and methods for providing prolonged local anesthesia
US59422526 juin 199524 août 1999Southern Research Institute
The UAB Research Foundation
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release
US59451158 août 199731 août 1999Atrix Laboratories, Inc.Polymeric compositions useful as controlled release implants
US59816947 nov. 19979 nov. 1999Cargill, IncorporatedMelt-stable lactide polymer composition and process for manufacture thereof
US598946324 sept. 199723 nov. 1999Alkermes Controlled Therapeutics, Inc.Methods for fabricating polymer-based controlled release devices
US59901947 nov. 199723 nov. 1999Atrix Laboratories, Inc.Biodegradable in-situ forming implants and methods of producing the same
US600506728 janv. 199821 déc. 1999Cargill IncorporatedContinuous process for manufacture of lactide polymers with controlled optical purity
US600506820 juil. 199821 déc. 1999Cargill IncorporatedMelt-stable amorphous lactide polymer film and process for manufacture thereof
US601385315 févr. 199411 janv. 2000The University of Texas SystemContinuous release polymeric implant carrier
US60204735 déc. 19951 févr. 2000Genentech, Inc.Nucleic acids encoding variants of vascular endothelial cell growth factor
US60249837 sept. 199315 févr. 2000Southern Research Institute
The Uab Research Foundation
Composition for delivering bioactive agents for immune response and its preparation
US604618716 sept. 19964 avr. 2000Children's Medical Center CorporationFormulations and methods for providing prolonged local anesthesia
US60574282 août 19962 mai 2000Genentech, Inc.Variants of vascular endothelial cell growth factor
US607153026 juin 19976 juin 2000Atrix Laboratories, Inc.Method and composition for treating a bone tissue defect
US607198218 avr. 19976 juin 2000Cambridge Scientific, Inc.Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
US609092519 août 199618 juil. 2000Epic Therapeutics, Inc.Macromolecular microparticles and methods of production and use
US60937919 mars 199825 juil. 2000Cargill, IncorporatedMelt-stable semi-crystalline lactide polymer film and process for manufacture thereof
US610926930 avr. 199929 août 2000Medtronic, Inc.Method of treating addiction by brain infusion
US61110602 janv. 199829 août 2000Cargill, IncorporatedMelt-stable lactide polymer nonwoven fabric and process for manufacture thereof
US612078930 mars 199919 sept. 2000Atrix Laboratories, Inc.Non-polymeric sustained release delivery system
US612141027 juil. 199919 sept. 2000Cargill, IncorporatedMelt-stable semi-crystalline lactide polymer film and process for manufacture thereof
US612395716 juil. 199726 sept. 2000Delivery of agents and method for regeneration of periodontal tissues
US61269197 févr. 19973 oct. 20003M Innovative Properties CompanyBiocompatible compounds for pharmaceutical drug delivery systems
US614331428 oct. 19987 nov. 2000Atrix Laboratories, Inc.Controlled release liquid delivery compositions with low initial drug burst
US614386311 mai 19997 nov. 2000Cargill, IncorporatedMelt-stable lactide polymer composition and process for manufacture thereof
US61531295 mai 199928 nov. 2000Alkermes Controlled Therapeutics, Inc.Production scale method of forming microparticles
US617178826 sept. 19979 janv. 2001The Regents of the University of CaliforniaMethods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US61742994 déc. 199816 janv. 2001Method for treating hemophilia A and B and AIDS and devices used therein
US62035565 août 199920 mars 2001Kensey Nash CorporationTransmyocardial revascularization system and method of use
US62038139 oct. 199820 mars 2001Pharmaceutical delivery device and method of preparation therefor
US620779227 juil. 199927 mars 2001Cargill, IncorporatedMelt-stable amorphous lactide polymer film and process for manufacture thereof
US623870212 juil. 199929 mai 2001Children's Medical Center Corp.High load formulations and methods for providing prolonged local anesthesia
US62483452 juil. 199819 juin 2001Euro-Celtique, S.A.Prolonged anesthesia in joints and body spaces
US627795113 juil. 199921 août 2001Cargill, IncorporatedContinuous process for manufacture of lactide polymers with controlled optical purity
US63064257 avr. 200023 oct. 2001Southern Research InstituteInjectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US63264587 oct. 19934 déc. 2001Cargill, Inc.Continuous process for the manufacture of lactide and lactide polymers
US63530303 juin 19985 mars 2002Novartis AGRelating to organic compounds
US63557729 mai 200012 mars 2002Cargill, IncorporatedMelt-stable lactide polymer nonwoven fabric and process for manufacture thereof
US63584436 juin 200019 mars 2002Alkermes Controlled Therapeutics, Inc.Production scale method of forming microparticles
US636863023 mars 19999 avr. 2002Alkermes Controlled Therapeutics, Inc.Modulated release from biocompatible polymers
US63952938 mars 200028 mai 2002Atrix LaboratoriesBiodegradable implant precursor
US64167429 août 20009 juil. 20023M Innovative Properties CompanyMedicinal aerosol solution formulation with biocompatible polymer
US64263393 avr. 200030 juil. 2002Children's Medical Center CorporationFormulations and methods for providing prolonged local anesthesia
US64757247 mai 19995 nov. 2002The Regents of the University of CaliforniaNucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US650389430 août 20007 janv. 2003Unimed Pharmaceuticals, Inc.
Laboratories Besins Iscovesco
Pharmaceutical composition and method for treating hypogonadism
US65142711 févr. 20014 févr. 2003Kensey Nash CorporationTransmyocardial revascularization system and method of use
US651451629 juin 19994 févr. 2003Euro-Celtique, S.A.Formulations and methods for providing prolonged local anesthesia
US651453322 sept. 19974 févr. 2003Alkermas Controlled Therapeutics, Inc.Device for the sustained release of aggregation-stabilized, biologically active agent
US652125910 mars 200018 févr. 2003Euro-Celtique S.A.Formulations and methods for providing prolonged local anesthesia
US65340812 avr. 200118 mars 2003Euro-Celtique S.A.Prolonged anesthesia in joints and body spaces
US654830218 juin 199915 avr. 2003Johns Hopkins University School of MedicinePolymers for delivery of nucleic acids
US657624624 mai 200010 juin 2003Seefar Technologies, Inc.Degradable animal chewing article possessing enhanced safety, durability and mouth-feel
US657953330 nov. 199917 juin 2003Bioasborbable Concepts, Ltd.Bioabsorbable drug delivery system for local treatment and prevention of infections
US662760019 janv. 200130 sept. 2003Ardana Bioscience LimitedCompressed microparticles for dry injection
US668275424 nov. 199927 janv. 2004Willmar Poultry Company, Inc.Ovo delivery of an immunogen containing implant
US669990826 sept. 20012 mars 2004Euro-Celtique, S.A.Methods for providing safe local anesthesia
US67094275 août 199923 mars 2004Kensey Nash CorporationSystems and methods for delivering agents into targeted tissue of a living being
US67268606 déc. 200127 avr. 2004Alkermes Controlled Therapeutics, Inc.Production scale method of forming microparticles
US67498663 janv. 200215 juin 2004Alkermes Controlled Therapeutics, Inc.Modulated release from biocompatible polymers
US69215419 sept. 200226 juil. 2005Euro-Celtique S.A.Formulations and methods for providing prolonged local anesthesia
US695568121 nov. 200218 oct. 2005Kensey Nash CorporationTransmyocardial revascularization system and method of use
US695815821 mars 200225 oct. 2005Ortho-McNeil Pharmaceutical, Inc.Immune modulation device for use in animals
US697213321 avr. 20036 déc. 2005Seefar Technologies, Inc.Degradable animal chewing article possessing enhanced safety, durability and mouth-feel
US70055051 juil. 199928 févr. 2006Genentech, Inc.Variants of vascular endothelial cell growth factor
US703745023 févr. 20042 mai 2006Alkermes Controlled Therapeutics, Inc.Production scale method of forming microparticles
US706029931 déc. 200313 juin 2006Battelle Memorial InstituteBiodegradable microparticles that stabilize and control the release of proteins
US70783822 nov. 200018 juil. 2006Genentech, Inc.Modulation of eNOS activity and therapeutic uses thereof
US709441924 juin 200322 août 2006Method of obtaining immune cells from an animal
US712892714 avr. 199831 oct. 2006QLT USA, Inc.Emulsions for in-situ delivery systems
US713851111 janv. 199921 nov. 2006The Regents of the University of CaliforniaNucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US715688014 août 20032 janv. 2007Kensey Nash CorporationDevices and methods for treating defects in the tissue of a living being
US716613313 juin 200223 janv. 2007Kensey Nash CorporationDevices and methods for treating defects in the tissue of a living being
US723510714 nov. 200326 juin 2007Devices and methods for treating defects in the tissue of a living being
US724131631 juil. 200310 juil. 2007Devices and methods for treating defects in the tissue of a living being
US741948223 janv. 20042 sept. 2008Kensey Nash CorporationSystems and methods for delivering agents into targeted tissue of a living being
US74275963 juin 200523 sept. 2008Genentech, Inc.Variants of vascular endothelial cell growth factor, their uses, and processes for their production
US74762349 mars 200513 janv. 2009Kensey Nash CorporationTransmyocardial revascularization system and method of use
US759490017 avr. 200229 sept. 2009Kensey Nash CorporationSystems and methods for delivering agents into targeted tissue of a living being
US768705418 févr. 200230 mars 20103M Innovative Properties CompanyBiocompatible compounds for sustained release pharmaceutical drug delivery systems
US788759827 oct. 200715 févr. 2011Kensey Nash BVF Technology, LLCDevices and methods for treating defects in the tissue of a living being
US78922917 oct. 200822 févr. 2011Kensey Nash BVF Technology, LLCDevices and methods for treating defects in the tissue of a living being
US789716813 avr. 20071 mars 2011Medtronic Vascular, Inc.Degradable polymers incorporating gamma-butyrolactone
US816303222 févr. 201124 avr. 2012Kensey Nash BVF Technology, LLCDevices and methods for treating defects in the tissue of a living being
US818764013 janv. 200929 mai 2012Dunn Research & Consulting, LLCLow viscosity liquid polymeric delivery system
US82265985 août 200324 juil. 2012Tolmar Therapeutics, Inc.Coupling syringe system and methods for obtaining a mixed composition
USRE3795028 mars 200031 déc. 2002Atrix LaboratoriesBiogradable in-situ forming implants and methods of producing the same

Dessins